首页> 外文OA文献 >Impact of pharmacy-led medication reconciliation on medication errors during transition in the hospital setting
【2h】

Impact of pharmacy-led medication reconciliation on medication errors during transition in the hospital setting

机译:药房LED药物和解对医院环境过渡期药物误差的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: To assess if the pharmacy department should be more involved in the medication reconciliation process to assist in the reduction of medication errors that occur during transition of care points in the hospital setting.Methods: This was an observational prospective cohort study at a 531-bed hospital in Pensacola, FL from June 1, 2014 to August 31, 2014. Patients were included in the study if they had health insurance and were taking five or more medications. Patients with congestive heart failure were excluded from the study. Student pharmacists collected and evaluated medication histories obtained from patients’ community pharmacies, and directed patient interviews. Primary care providers were only contacted on an as needed basis. The information collected was presented to the clinical pharmacist, where interventions were made utilizing clinical judgment.Results: During the three month study, 1045 home medications were reviewed by student pharmacist. Of these, 290 discrepancies were discovered (27.8%; p=0.02). The most common medication discrepancy found was dose optimization (45.5%). The remaining discrepancies included: added therapy (27.6%), other (15.2%), and discontinued therapy (11.7%). Pharmacists made 143 interventions based on clinical judgment (49.3%; p=0.04).Conclusion: Involvement of pharmacy personnel during the medication reconciliation process can be an essential component in reducing medical errors. With the addition of the pharmacy department during the admission process, accuracy, cost savings, and patient safety across all phases and transition points of care were achieved.
机译:目的:评估药房部门是否应更加参与药物和解进程,以协助减少医院环境中护理点转移期间发生的药物错误。方法:这是2014年6月1日至2014年6月1日至8月31日的Pensacola 531床医院的观察前景队列研究。如果他们有健康保险,患者患者被纳入研究,并服用五种或更多的药物。患有充血性心力衰竭的患者被排除在研究之外。学生药剂师收集和评估了从患者社区药房获得的药物历史,并导向患者访谈。初级护理提供者仅根据需要联系。收集的信息呈现给临床药剂师,其中利用临床判断进行干预。结果:在三个月的研究中,学生药剂师审查了1045家家庭药物。其中,发现了290个差异(27.8%; P = 0.02)。发现的最常见的药物差异是剂量优化(45.5%)。剩余的差异包括:添加治疗(27.6%),其他(15.2%)和已停止治疗(11.7%)。药剂师根据临床判断制作了143次干预(49.3%; P = 0.04)。结论:药房人员在药物和解过程中的参与可以是减少医疗错误的重要组成部分。随着药房部门的加入过程中的加入,准确性,成本节约和患者在所有阶段和过渡点的安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号